BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30086269)

  • 1. The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
    Feng P; Zhao L; Guo F; Zhang B; Fang L; Zhan G; Xu X; Fang Q; Liang Z; Li B
    Chem Biol Interact; 2018 Sep; 293():115-123. PubMed ID: 30086269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides.
    Zhi D; Feng PF; Sun JL; Guo F; Zhang R; Zhao X; Li BX
    Eur J Pharm Sci; 2015 Aug; 76():149-55. PubMed ID: 25976224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency.
    Yan M; Zhang K; Shi Y; Feng L; Lv L; Li B
    Drug Des Devel Ther; 2015; 9():5737-47. PubMed ID: 26543354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytochrome P450 3A4‑mediated drug‑drug interaction potential between P2Y12 inhibitors and statins.
    Zhang B; Zhan G; Fang Q; Wang F; Li Y; Zhang Y; Zhao L; Zhang G; Li B
    Mol Med Rep; 2019 Nov; 20(5):4713-4722. PubMed ID: 31545497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of berberine, liensinine and neferine on HERG channel expression].
    Wei T; Liang Z; Jin Y; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):239-44. PubMed ID: 23672049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a new mexiletine-derived agonist of the hERG K
    Gualdani R; Cavalluzzi MM; Tadini-Buoninsegni F; Lentini G
    Biophys Chem; 2017 Oct; 229():62-67. PubMed ID: 28673509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
    Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
    Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.
    Aromolaran AS; Srivastava U; Alí A; Chahine M; Lazaro D; El-Sherif N; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
    PLoS One; 2018; 13(12):e0208321. PubMed ID: 30521586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin.
    Park JE; Kim KB; Bae SK; Moon BS; Liu KH; Shin JG
    Xenobiotica; 2008 Sep; 38(9):1240-51. PubMed ID: 18720283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine induces hERG channel deficiency through trafficking inhibition.
    Zhang K; Zhi D; Huang T; Gong Y; Yan M; Liu C; Wei T; Dong Z; Li B; Yang B
    Cell Physiol Biochem; 2014; 34(3):691-702. PubMed ID: 25171176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia reduces mature hERG channels through calpain up-regulation.
    Lamothe SM; Song W; Guo J; Li W; Yang T; Baranchuk A; Graham CH; Zhang S
    FASEB J; 2017 Nov; 31(11):5068-5077. PubMed ID: 28784631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epicatechin rescues the As
    Dong Z; Shi Y; Feng L; Shen Z; Fang L; Zheng S; Hai X; Li B
    J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28768059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.
    He S; Moutaoufik MT; Islam S; Persad A; Wu A; Aly KA; Fonge H; Babu M; Cayabyab FS
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188355. PubMed ID: 32135169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico assessment of kinetics and state dependent binding properties of drugs causing acquired LQTS.
    Lee W; Mann SA; Windley MJ; Imtiaz MS; Vandenberg JI; Hill AP
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):89-99. PubMed ID: 26713558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hERG channel trafficking: novel targets in drug-induced long QT syndrome.
    Dennis A; Wang L; Wan X; Ficker E
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1060-3. PubMed ID: 17956279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells.
    Cui HM; Zhang QY; Wang JL; Chen JL; Zhang YL; Tong XL
    J Ethnopharmacol; 2014 Dec; 158 Pt A():388-96. PubMed ID: 25456436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.